GLP-1 RAs Linked to Higher Hair Loss Risk - Top-Institutions - MDSpire

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

  • By

  • Kerri Miller

  • February 19, 2026

  • 3 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Dermatology
    • Clinical Pharmacology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Dermatology
    • Pharmacovigilance

  • #3

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Dermatology
    • Epidemiology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Dermatology
    • Clinical Research

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Dermatology
    • Pharmacology

Original Source(s)

GLP-1 RAs Linked to Higher Hair Loss Risk

  • by Kerri Miller

  • February 19, 2026

Related Content

Medical Oddities: Brain Health, Sunny-Side Up

Breakfast, bacteria, and brain wiring—small things show big implications this week.

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

Case Report: rapid progressive puberty in siblings with MC4R p. Arg165Gln: longitudinal follow-up and gonadotropin-releasing hormone agonist treatment